Loading...
Loading...
BioScience Health Innovations, Inc.
BioScience Health Innovations, Inc.. Spoken Alpha tracks BHIC's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BHIC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 5/10 quarters with 10% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BHIC.
curl https://api.spokenalpha.com/v1/companies/BHIC| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.88 | $3.86 | +0.6% | -3.1% | -4.8% |
| Q4 FY2026 | $3.93 | $3.82 | +3.0% | -0.8% | -3.5% |
| Q3 FY2026 | $3.43 | $3.84 | -10.8% | +0.8% | +2.9% |
| Q2 FY2026 | $3.49 | $3.89 | -10.4% | -9.4% | -7.2% |
| Q1 FY2025 | $4.08 | $3.94 | +3.6% | -6.8% | -8.3% |
| Q4 FY2025 | $3.74 | $3.90 | -4.0% | -6.2% | -4.3% |
| Q3 FY2025 | $3.58 | $3.90 | -8.3% | -3.7% | -3.0% |
| Q2 FY2025 | $3.94 | $3.86 | +2.2% | -0.7% | -2.9% |
| Q1 FY2024 | $3.74 | $3.94 | -5.1% | -8.6% | -8.4% |
| Q4 FY2024 | $4.09 | $3.97 | +3.0% | -3.4% | -4.2% |